The safety and effectiveness of endoscopic and non-endoscopic approaches to the management of early esophageal cancer: A systematic review

Cancer Treatment Reviews

Volumn 37, Issue 1, 2011, Pages 11-62

  McCann, Paul ^a   Stafinski, Tania ^a   Wong, Clarence ^b   Menon, Devidas ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b ROYAL ALEXANDRA HOSPITAL   (Canada)

Author keywords

Argon plasma coagulation; Chemotherapy; Cryoablation; Early esophageal cancer; Effectiveness; Endoscopic mucosal resection; Esophagectomy; Photodynamic therapy; Radio frequency ablation; Radiotherapy; Safety; Systematic review

Indexed keywords

AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; CAPECITABINE; CARBOPLATIN; CISPLATIN; DOCETAXEL; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; HEMATOPORPHYRIN DERIVATIVE; IRINOTECAN; NEDAPLATIN; PACLITAXEL; PHOTOFRIN; PHOTOFRIN I; PHOTOFRIN II; PROTON PUMP INHIBITOR; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; VINDESINE;

ABDOMINAL PAIN; ADULT RESPIRATORY DISTRESS SYNDROME; ANASTOMOSIS LEAKAGE; ANEMIA; ANGINA PECTORIS; ARGON PLASMA COAGULATION; BLEEDING; BLOOD TRANSFUSION; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CINAHL; COCHRANE LIBRARY; CONTINUOUS INFUSION; CRYOTHERAPY; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DYSPHAGIA; EMBASE; EMPYEMA; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC SUBMUCOSAL DISSECTION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS CANCER; ESOPHAGUS FISTULA; ESOPHAGUS PERFORATION; ESOPHAGUS STENOSIS; ESOPHAGUS STRICTURE; ESOPHAGUS ULCER; FATIGUE; FEVER; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEMATOMA; HUMAN; HYPOTHYROIDISM; INTERNET; KIDNEY FAILURE; LEUKOPENIA; MEDLINE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEPHROTOXICITY; NERVE PARALYSIS; NEUTROPENIA; OVERALL SURVIVAL; PERICARDIAL EFFUSION; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PLEURA EFFUSION; PNEUMONIA; POSTGASTRECTOMY SYNDROME; PRACTICE GUIDELINE; RADIOFREQUENCY ABLATION; RESPIRATORY TRACT DISEASE; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; THORAX PAIN; THROMBOCYTOPENIA; TRACHEOESOPHAGEAL FISTULA; ULCER; VOMITING; WOUND INFECTION;

COMBINED MODALITY THERAPY; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; HUMANS; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 78649865873     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2010.04.006     Document Type: Review

References (269)

1. Sampliner R.E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 1998, 93(7):1028-1032.
2. Smith A.M., Maxwell-Armstrong C.A., Welch N.T., Scholefield J.H. Surveillance for Barrett's oesophagus in the UK. Brit J Surg 1999, 86(2):276-280.
3. Yousef F., Cardwell C., Cantwell M.M., Galway K., Johnston B.T., Murray L. The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol 2008, 168(3):237-249.
4. Clifton J.C., Finley R.J., Gelfand G., Graham A.J., Inculet R., Malthaner R., et al. Development and validation of a disease-specific quality of life questionnaire (EQOL) for potentially curable patients with carcinoma of the esophagus. Dis Esophagus 2007, 20(3):191-201.
5. Cancer Care Ontario. The most fatal cancers in Ontario [Ontario Cancer Facts; November 2005]. Toronto: Cancer Care Ontario; 2005. http://www.cancercare.on.ca/english/home/ocs/snapshot/ont-cancer-facts/mostfatal/.
6. Phillips C. The curious rise of esophageal adenocarcinoma. NCI Cancer Bull 2006;3(20):3-5. http://www.cancer.gov/NCICancerBulletin/NCI_Cancer_Bulletin_051606.pdf.
7. Vizcaino A.P., Moreno V., Lambert R., Parkin D.M. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 2002, 99(6):860-868.
8. Cancer Research UK. Oesophageal cancer: UK incidence statistics. London: Cancer Research UK; 2009. http://info.cancerresearchuk.org/cancerstats/types/oesophagus/incidence/.
9. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55(2):74-108.
10. Kamangar F., Dores G.M., Anderson W.F. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24(14):2137-2150.
11. Eslick GD. Epidemiology of esophageal cancer. Gastroenterol Clin North Am 2009;38:17-25. http://www.mdconsult.com/das/article/body/160674468-2/jorg=journal&source=&sp=21972283&sid=0/N/692022/s0889855309000107.pdf?issn=0889-8553.
12. Pohl H., Welch H.G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005, 97(2):142-146.
13. Cancer Care Ontario. Changing patterns of esophageal cancer: adenocarcinoma on the rise [Ontario Cancer Facts]. Toronto: Cancer Care Ontario; 2008. http://www.cancercare.on.ca/documents/CF_July2008-esophageal-adenocaontherise.pdf.
14. Barritt A.S., Shaheen N.J. Should patients with Barrett's oesophagus be kept under surveillance? The case against. Best Pract Res Clin Gastroenterol 2008, 22(4):741-750.
15. SSAT patient care guidelines. Surgical treatment of esophageal cancer. J Gastrointest Surg 2007;11(9):1216-8.
16. Ragunath K., Krasner N., Raman V.S., Haqqani M.T., Phillips C.J., Cheung I. Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand J Gastroenterol 2005, 40(7):750-758.
17. Caldwell M.T., Lawlor P., Byrne P.J., Walsh T.N., Hennessy T.P. Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus. Brit J Surg 1995, 82(5):657-660.
18. Vaezi M.F., Richter J.E. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 1995, 117(6):699-704.
19. American Cancer Society. What is cancer of the esophagus? American Cancer Society; 2009. http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_is_esophagus_cancer_12.asp.
20. Wani S., Mathur S., Sharma P. How to manage a Barrett's esophagus patient with low-grade dysplasia. Clin Gastroenterol Hepatol 2009, 7(1):27-32.
21. Basu K.K., Pick B., de Caestecker J.S. Audit of a Barrett's epithelium surveillance database. Eur J Gastroenterol Hepatol 2004, 16(2):171-175.
22. Skacel M., Petras R.E., Gramlich T.L., Sigel J.E., Richter J.E., Goldblum J.R. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression. Am J Gastroenterol 2000, 95(12):3383-3387.
23. American Joint Committee on Cancer AJCC cancer staging manual 2002, Springer, New York. 6th ed.
24. Corti L., Skarlatos J., Boso C., Cardin F., Kosma L., Koukourakis M.I., et al. Outcome of patients receiving photodynamic therapy for early esophageal cancer. Int J Radiat Oncol Biol Phys 2000, 47(2):419-424.
25. Seewald S., Ang T.L., Groth S., Zhong Y., Bertschinger P., Altorfer J., et al. Detection and endoscopic therapy of early esophageal adenocarcinoma. Curr Opin Gastroenterol 2008, 24(4):521-529.
26. Petersen B.T., Chuttani R., Croffie J., DiSario J., Liu J., Mishkin D., et al. Photodynamic therapy for gastrointestinal disease. Gastrointest Endosc 2006, 63(7):927-932.
27. Shaheen N.J., Sharma P., Overholt B.F., Wolfsen H.C., Sampliner R.E., Wang K.K., et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. New Eng J Med 2009, 360(22):2277-2288.
28. Green S., Tawil A., Barr H., Bennett C., Bhandari P., DeCaestecker J., et al. Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. Cochrane Library 2009, (2).
29. Jacobson B.C., Hirota W., Baron T.H., Leighton J.A., Faigel D.O. The role of endoscopy in the assessment and treatment of esophageal cancer. Gastrointest Endosc 2003, 57(7):817-822.
30. Johnston M.H. Cryotherapy and other newer techniques. Gastrointest Endosc Clin N Am 2003, 13(3):491-504.
31. McAllaster J.D., Buckles D., Al-Kasspooles M. Treatment of Barrett's esophagus with high-grade dysplasia. Expert Rev Anticancer Ther 2009, 9(3):303-316.
32. Kantsevoy S.V., Adler D.G., Conway J.D., Diehl D.L., Farraye F.A., Kwon R., et al. Endoscopic mucosal resection and endoscopic submucosal dissection. Gastrointest Endosc 2008, 68(1):11-18.
33. Systematic reviews in health care: meta-analysis in context. Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ; 2001.
34. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960, 20(1):37-46.
35. The Cochrane Collaboration. RevMan. Oxford, UK: The Cochrane Collaboration; 2010. http://www.cc-ims.net/revman.
36. Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, et al. Oxford Centre for Evidence-Based Medicine levels of evidence and grades of recommendation. Oxford, UK: Oxford Centre for Evidence-Based Medicine; 2001. http://www.cebm.net/index.aspx?o=1047.
37. Tan W.C., Fulljames C., Stone N., Dix A.J., Shepherd N., Roberts D.J., et al. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia. J Photochem Photobiol B 1999, 53(1-3):75-80.
38. Nomura T. Argon plasma coagulation for the treatment of superficial esophageal carcinoma. J Nippon Med Sch 2007, 74(2):163-167.
39. Van Laethem J.L., Jagodzinski R., Peny M.O., Cremer M., Deviere J. Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy 2001, 33(3):257-261.
40. Dumot J.A., Greenwald B.D. Argon plasma coagulation, bipolar cautery, and cryotherapy: ABC's of ablative techniques. Endoscopy 2008, 40(12):1026-1032.
41. Craig C., Gray J., Macpherson M., Hodgson H., Zammit M., Fullarton G. Porfimer sodium photodynamic therapy in the treatment of early oesophageal carcinoma. Photodiagn Photodyn Ther 2007, 4(4):244-248.
42. Duvall G.A., Scheider D., Cirocco M., Siemens M., Marcon N. Photodynamic therapy (PDT) for early esophageal cancer in high risk surgical patients and patients refusing esophagectomy. Gastrointest Endosc 1996, 43(4):334. [abstract].
43. Etienne J., Dorme N., Bourg-Heckly G., Raimbert P., Flejou J.F. Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc 2004, 59(7):880-889.
44. Foroulis C.N., Thorpe J.A. Photodynamic therapy (PDT) in Barrett's esophagus with dysplasia or early cancer. Eur J Cardiothorac Surg 2006, 29(1):30-34.
45. Gossner L., May A., Pech O. Photodynamic therapy of Barrett's esophagus with dysplasia or early cancer. Gastroenterology 1999, 116(Suppl):G1811. [abstract].
46. Gossner L., May A., Sroka R., Stolte M., Hahn E.G., Ell C. Photodynamic destruction of high grade dysplasia and early carcinoma of the esophagus after the oral administration of 5-aminolevulinic acid. Cancer 1999, 86(10):1921-1928.
47. Jamieson N.F., Mosse A., Bown S.G., Lovat L.B. Photodynamic therapy to eradicate dysplasia and early carcinoma in Barrett's oesophagus. Gut 2002, 50(Suppl 2):A6-A7. [abstract].
48. Keeley S.B., Pennathur A., Gooding W., Landreneau R.J., Christie N.A., Luketich J. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann Surg Oncol 2007, 14(8):2406-2410.
49. Lovat L.B., Jamieson N.F., Novelli M.R., Mosse C.A., Selvasekar C., Mackenzie G.D., et al. Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. Gastrointest Endosc 2005, 62(4):617-623.
50. Maunoury V., Mordon S., Bulois P., Mirabel X., Hecquet B., Mariette C. Photodynamic therapy for early oesophageal cancer. Dig Liver Dis 2005, 37(7):491-495.
51. McCaughan J.S., Ellison E.C., Guy J.T., Hicks W.J., Jones J.J., Laufman L.R., et al. Photodynamic therapy for esophageal malignancy: a prospective 12-year study. Ann Thorac Surg 1996, 62(4):1005-1009.
52. Messmann H., Szeimies R.M., Baumler W., Knuchel R., Zirngibl H., Scholmerich J., et al. Enhanced effectiveness of photodynamic therapy with laser light fractionation in patients with esophageal cancer. Endoscopy 1997, 29(4):275-280.
53. Moghissi K., Dixon K. Photodynamic therapy (PDT) in esophageal cancer: a surgical view of its indications based on 14 years experience. Technol Cancer Res Treat 2003, 2(4):319-326.
54. Nakamura T., Fukui H., Shirakawa K., Fujii Y., Fujimori T., Terano A. Photodynamic therapy of superficial esophageal cancer with a transparent hood. Gastrointest Endosc 2004, 60(1):120-124.
55. Okunaka T., Kato H., Conaka C., Yamamoto H., Bonaminio A., Eckhauser M.L. Photodynamic therapy of esophageal carcinoma. Surg Endosc 1990, 4(3):150-153.
56. Overholt B.F., Panjehpour M. Photodynamic therapy in Barrett's esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer. Semin Surg Oncol 1995, 11(5):372-376.
57. Overholt B.F., Panjehpour M., Ayres M. Photodynamic therapy for Barrett's esophagus: cardiac effects. Lasers Surg Med 1997, 21(4):317-320.
58. Overholt B.F., Panjehpour M., Halberg D.L. Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 2003, 58(2):183-188.
59. Savoy A.D., Wolfsen H.C., Raimondo M., Woodward T.A., Noh K., Pungpapong S., et al. The role of surveillance endoscopy and endosonography after endoscopic ablation of high-grade dysplasia and carcinoma of the esophagus. Dis Esophagus 2008, 21(2):108-113.
60. Shim C.S., Cheon Y.K., Jung I.S., Ko B.M., Cho J.Y., Lee J.S., et al. Photodynamic therapy for early esophageal cancer. Gastrointest Endosc 2007, 65(5 Suppl):AB149. [abstract].
61. Yachimski P., Puricelli W.P., Nishioka N.S. Patient predictors of esophageal stricture development after photodynamic therapy. Clin Gastroenterol Hepatol 2008, 6(3):302-308.
62. Yano T, Muto M, Minashi K, Ohtsu A, Yoshida S. Salvage photodynamic therapy (PDT) for local failure after definitive chemoradiotherapy (CRT) for esophageal cancer (EC). 2006 Gastrointestinal Cancers Symposium 2006;Abstract #34 [abstract]. http://www.asco.org.
63. Yoshida K., Suzuki S., Mimura S., Narahara H., Tanimura H., Nagai Y., et al. A clinical study of photodynamic therapy for superficial esophageal carcinoma by YAG-OPO Laser. Diagn Ther Endosc 1998, 4(4):173-176.
64. Pacifico R.J., Wang K.K., Wongkeesong L.M., Buttar N.S., Lutzke L.S. Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol 2003, 1(4):252-257.
65. Pouw R.E., Gondrie J.J., Sondermeijer C.M., Ten Kate F.J., van Gulik T.M., Krishnadath K.K., et al. Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg 2008, 12(10):1627-1636.
66. Conio M., Repici A., Cestari R., Blanchi S., Lapertosa G., Missale G., et al. Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience. World J Gastroenterol 2005, 11(42):6650-6655.
67. Ell C., May A., Pech O., Gossner L., Guenter E., Behrens A., et al. Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer). Gastrointest Endosc 2007, 65(1):3-10.
68. Giovannini M., Bories E., Pesenti C., Moutardier V., Monges G., Danisi C., et al. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy 2004, 36(9):782-787.
69. Katada C., Muto M., Momma K., Arima M., Tajiri H., Kanamaru C., et al. Clinical outcome after endoscopic mucosal resection for esophageal squamous cell carcinoma invading the muscularis mucosae - a multicenter retrospective cohort study. Endoscopy 2007, 39(9):779-783.
70. Lopes C.V., Hela M., Pesenti C., Bories E., Caillol F., Monges G., et al. Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Surg Endosc 2007, 21(5):820-824.
71. Manner H., May A., Pech O., Gossner L., Rabenstein T., Gunter E., et al. Early Barrett's carcinoma with " low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 2008, 103:2589-2597.
72. Pech O., May A., Gossner L., Rabenstein T., Manner H., Huijsmans J., et al. Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy 2007, 39(1):30-35.
73. Seewald S., Akaraviputh T., Seitz U., Brand B., Groth S., Mendoza G., et al. Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003, 57(7):854-859.
74. Shimizu Y. Histologic results of EMR for esophageal lesions diagnosed as high-grade intraepithelial squamous neoplasia by endoscopic biopsy. Gastrointest Endosc 2006, 63(1):16-21.
75. Tanabe S., Koizumi W., Higuchi K., Sasaki T., Nakatani K., Hanaoka N., et al. Clinical outcomes of endoscopic oblique aspiration mucosectomy for superficial esophageal cancer. Gastrointest Endosc 2008, 67(6):814-820.
76. Ishihara R., Iishi H., Takeuchi Y., Kato M., Yamamoto S., Yamamoto S., et al. Local recurrence of large squamous-cell carcinoma of the esophagus after endoscopic resection. Gastrointest Endosc 2008, 67(6):799-804.
77. Tanabe S., Koizumi W., Mitomi H., Kitamura T., Tahara K., Ichikawa J., et al. Usefulness of EMR with an oblique aspiration mucosectomy device compared with strip biopsy in patients with superficial esophageal cancer. Gastrointest Endosc 2004, 59(4):558-563.
78. Benzoni E., Terrosu G., Bresadola V., Uzzau A., Intini S., Noce L., et al. A comparative study of the transhiatal laparoscopic approach versus laparoscopic gastric mobilisation and right open transthoracic esophagectomy for esophageal cancer management. J Gastrointest Liver Dis 2007, 16(4):395-401.
79. Braghetto I., Csendes A., Cardemil G., Burdiles P., Korn O., Valladares H. Open transthoracic or transhiatal esophagectomy versus minimally invasive esophagectomy in terms of morbidity, mortality and survival. Surg Endosc 2006, 20(11):1681-1686.
80. Peyre C.G., DeMeester S.R., Rizzetto C., Bansal N., Tang A.L., Ayazi S., et al. Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Ann Surg 2007, 246(4):665-671.
81. Smithers B.M., Gotley D.C., Martin I., Thomas J.M. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg 2007, 245(2):232-240.
82. Hironaka S., Ohtsu A., Boku N., Muto M., Nagashima F., Saito H., et al. Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any)M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 2003, 57(2):425-433.
83. Heroor A. Adjuvant chemotherapy after radical resection of squamous cell carcinoma in the thoracic esophagus: who benefits? A retrospective study. Dig Surg 2003, 20(3):229-235.
84. Javle M.M. Management of locoregional stage esophageal cancer: a single center experience. Dis Esophagus 2006, 19(2):78-83.
85. Thomson B.N.J., Cade R.J. Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus. ANZ J Surg 2003, 73(3):121-124.
86. Kawashima M., Kagami Y., Toita T., Uno T., Sugiyama M., Tamura Y., et al. Prospective trial of radiotherapy for patients 80 years of age or older with squamous cell carcinoma of the thoracic esophagus. Int J Radiat Oncol Biol Phys 2006, 64(4):1112-1121.
87. Kodaira T. Multivariate analysis of treatment outcome in patients with esophageal carcinoma treated with definitive radiotherapy. Am J Clin Oncol: Cancer Clin Trials 2003, 26(4):392-397.
88. Ishikawa H., Sakurai H., Tamaki Y., Nonaka T., Yamakawa M., Saito Y., et al. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy. J Gastroenterol Hepatol 2006, 21(8):1290-1296.
89. Sai H. Long-term results of definitive radiotherapy for stage I esophageal cancer. Int J Radiat Oncol Biol Phys 2005, 62(5):1339-1344.
90. Czito B.G., Kelsey C.R., Hurwitz H.I., Willett C.G., Morse M.A., Blobe G.C., et al. A phase I study of capecitabine, carboplatin, and paclitaxel with external beam radiation therapy for esophageal carcinoma. Int J Radiat Oncol Biol Phys 2007, 67(4):1002-1007.
91. Sato Y., Takayama T., Sagawa T., Okamoto T., Miyanishi K., Sato T., et al. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer. Cancer Chemother Pharmacol 2006, 58(5):570-576.
92. Wang S., Liao Z., Chen Y., Chang J.Y., Jeter M., Guerrero T., et al. Esophageal cancer located at the neck and upper thorax treated with concurrent chemoradiation: a single-institution experience. J Thorac Oncol 2006, 1(3):252-259.
93. Yamada K., Murakami M., Okamoto Y., Okuno Y., Nakajima T., Kusumi F., et al. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma. Int J Radiat Oncol Biol Phys 2006, 64(4):1106-1111.
94. Malaisrie S.C., Hofstetter W.L., Correa A.M., Ajani J.A., Komaki R.R., Rice D.C., et al. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 2006, 107(5):967-974.
95. Nemoto K. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Anticancer Res 2006, 26(2 B):1507-1512.
96. Sugahara S.T. Clinical results of proton beam therapy for cancer of the esophagus. Int J Radiat Oncol Biol Phys 2005, 61(1):76-84.
97. Zhao K.L. Late-course accelerated hyperfractionated radiotherapy for localized esophageal carcinoma. Int J Radiat Oncol Biol Phys 2004, 60(1):123-129.
98. de Manzoni G., Pedrazzani C., Laterza E., Pasini F., Grandinetti A., Bernini M., et al. Induction chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus: impact of increased dosage on long-term results. Ann Thorac Surg 2005, 80(4):1176-1183.
99. Donahue J.M., Nichols F.C., Li Z., Schomas D.A., Allen M.S., Cassivi S.D., et al. Complete pathologic response after neoadjuvant chemoradiotherapy for esophageal cancer is associated with enhanced survival. Ann Thorac Surg 2009, 87(2):392-398.
100. Moraca R.J. Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer. Arch Surg 2006, 141(6):545-549.
101. Nguyen N.T., Roberts P., Follette D.M., Rivers R., Wolfe B.M. Thoracoscopic and laparoscopic esophagectomy for benign and malignant disease: lessons learned from 46 consecutive procedures. J Am Coll Surg 2003, 197(6):902-913.
102. Westerterp M., Koppert L.B., Buskens C.J., Tilanus H.W., Ten Kate F.J.W., Bergman J.J.H.G., et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch 2005, 446(5):497-504.
103. Wolfsen HC, Hemminger LL, DeVault KR. Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy. BMC Gastroenterol 2004;4:18. http://www.biomedcentral.com/1471-230X/4/18/.
104. Alexiou C., Khan O.A., Black E., Field M.L., Onyeaka P., Beggs L., et al. Survival after esophageal resection for carcinoma: the importance of the histologic cell type. Ann Thorac Surg 2006, 82(3):1073-1077.
105. Egberts J.H., Schniewind B., Bestmann B., Schafmayer C., Egberts F., Faendrich F., et al. Impact of the site of anastomosis after oncologic esophagectomy on quality of life - a prospective, longitudinal outcome study. Ann Surg Oncol 2008, 15(2):566-5675.
106. Mariette C., Piessen G., Balon J.M., Van S.I., Triboulet J.P. Surgery alone in the curative treatment of localised oesophageal carcinoma. Eur J Surg Oncol 2004, 30(8):869-876.
107. Udagawa H. Surgical treatment of superficial esophageal cancer, its result and perspective. Esophagus 2007, 4(4):155-158.
108. Wang H.W. Surgical results of upper thoracic esophageal carcinoma. J Chin Med Assoc 2004, 67(9):447-457.
109. Wang G.Q. Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening. Ann Thorac Surg 2004, 77(5):1740-1744.
110. Yamamoto S.K. Minimally invasive esophagectomy for stage I and II esophageal cancer. Ann Thorac Surg 2005, 80(6):2070-2075.
111. National Institute for Health and Clinical Excellence. Audit criteria: photodynamic therapy for early-stage oesophageal cancer [Interventional Procedure Guidance], vol. 200. London: National Institute for Health and Clinical Excellence (NICE); 2006. http://www.nice.org.uk/guidance/IPG200.
112. Institute for Clinical Systems Improvement. Photodynamic therapy for head and neck, tracheobronchial, and esophageal cancer. Bloomington, MN: Institute for Clinical Systems Improvement (ICSI); 2002. http://www.icsi.org/technology_assessment_reports_-_active/ta_photodynamic_therapy_for_head_and_neck_tracheobronchial_and_esophageal_cancer.html.
113. Erickson L. Assessment of photodynamic therapy using porfimer sodium for esophageal, bladder and lung cancers. Montreal: Agence d'evaluation des technologies et des modes d'intervention en sante; 2004. http://www.aetmis.gouv.qc.ca/fr/publications/scientifiques/cancer/2004_01_res_en.pdf.
114. Urba S.G., Orringer M.B., Turrisi A., Iannettoni M., Forastiere A., Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001, 19(2):305-313.
115. Reed M.F., Tolis G., Edil B.H., Allan J.S., Donahue D.M., Gaissert H.A., et al. Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg 2005, 79(4):1110-1115.
116. Hulscher J.B., van Sandick J.W., de Boer A.G., Wijnhoven B.P., Tijssen J.G., Fockens P., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New Engl J Med 2002, 347(21):1662-1669.
117. Jamieson G.G., Mathew G., Ludemann R., Wayman J., Myers J.C., Devitt P.G. Postoperative mortality following oesophagectomy and problems in reporting its rate. Brit J Surg 2004, 91(8):943-947.
118. Reynolds J.V., McLaughlin R., Moore J., Rowley S., Ravi N., Byrne P.J. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Brit J Surg 2006, 93(9):1084-1090.
119. Qureshi I., Nason K.S., Luketich J.D. Is minimally invasive esophagectomy indicated for cancer?. Expert Rev Anticancer Ther 2008, 8(9):1449-1460.
120. Viklund P. Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer 2006, 42(10):1407-1414.
121. Whooley B.P., Law S., Murthy S.C., Alexandrou A., Wong J. Analysis of reduced death and complication rates after esophageal resection. Ann Surg 2001, 233(3):338-344.
122. National Cancer Institute. What you need to know about cancer of the esophagus [NIH Publication No. 08-1557]. Bethesda, MD: US National Institutes of Health, National Cancer Institute; 2009. http://www.cancer.gov/cancertopics/wyntk/esophagus.pdf.
123. Agranovich A., McGahan C.E., Gurjal A. Long-term survivorship of esophageal cancer patients treated with radical intent. Can J Gastroenterol 2008, 22(4):393-398.
124. Ajani J.A. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol 2008, 26(28):4551-4556.
125. Homesh N.A., Alsabahi A.A., Al-Agmar M.H., Alwashaly A.A., Valenzuela R.E., Alhadid M.A., et al. Transhiatal versus transthoracic resection for oesophageal carcinoma in Yemen. Singapore Med J 2006, 47(1):54-59.
126. Ancona E., Rampado S., Cassaro M., Battaglia G., Ruol A., Castoro C., et al. Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol 2008, 15(11):3278-3288.
127. Ando N., Iizuka T., Ide H., Ishida K., Shinoda M., Nishimaki T., et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study - JCOG9204. J Clin Oncol 2003, 21(24):4592-4596.
128. Benzoni E., Bresadola V., Terrosu G., Uzzau A., Cedolini C., Intini S., et al. Minimally invasive esophagectomy: a comparative study of transhiatal laparoscopic approach versus laparoscopic right transthoracic esophagectomy. Surg Laparosc Endosc Percutan Tech 2008, 18(2):178-187.
129. Bergquist H. Functional and radiological evaluation of free jejunal transplant reconstructions after radical resection of hypopharyngeal or proximal esophageal cancer. World J Surg 2007, 31(10):1988-1995.
130. Bernabe K.Q., Bolton J.S., Richardson W.S. Laparoscopic hand-assisted versus open transhiatal esophagectomy: a case-control study. Surg Endosc 2005, 19(3):334-337.
131. Blackmon S.H., Correa A.M., Wynn B., Hofstetter W.L., Martin L.W., Mehran R.J., et al. Propensity-matched analysis of three techniques for intrathoracic esophagogastric anastomosis. Ann Thorac Surg 2007, 83(5):1805-1813.
132. Bresadola V., Terrosu G., Cojutti A., Benzoni E., Baracchini E., Bresadola F. Laparoscopic versus open gastroplasty in esophagectomy for esophageal cancer: a comparative study. Surg Laparosc Endosc Percutan Tech 2006, 16(2):63-67.
133. Chang A.C. Outcomes after transhiatal and transthoracic esophagectomy for cancer. Ann Thorac Surg 2008, 85(2):424-429.
134. Chiu P.W., Chan A.C., Leung S.F., Leong H.T., Kwong K.H., Li M.K., et al. Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE). J Gastrointest Surg 2005, 9(6):794-802.
135. Chou S.H., Kao E.L., Chuang H.Y., Wang W.M., Wu D.C., Huang M.F. Transthoracic or transhiatal resection for middle- and lower-third esophageal carcinoma?. Kaohsiung J Med Sci 2005, 21(1):9-14.
136. Ciocirlan M., Chemali M., Lapalus M.G., Lefort C., Souquet J.C., Napoleon B., et al. Esophageal varices and early esophageal cancer: can we perform endoscopic mucosal resection (EMR)?. Endoscopy 2008, 40(Suppl 2):E91.
137. Dabrowski A., Skoczylas T., Ciechanski A., Wallner G., Zinkiewicz K., Cwik G., et al. Dukes' classification as a prognostic factor in patients with squamous cell carcinoma of the thoracic esophagus undergoing combined-modality treatment. Med Sci Monit 2006, 12(10):CR409-CR415.
138. Dan H.-L. A new three-layer-funnel-shaped esophagogastric anastomosis for surgical treatment of esophageal carcinoma. World J Gastroenterol 2003, 9(1):22-25.
139. Dapri G., Himpens J., Cadiere G.B. Minimally invasive esophagectomy for cancer: laparoscopic transhiatal procedure or thoracoscopy in prone position followed by laparoscopy?. Surg Endosc 2008, 22(4):1060-1069.
140. Darnton S.J., Archer V.R., Stocken D.D., Mulholland P.J., Casson A.G., Ferry D.R. Preoperative mitomycin, ifosfamide, and cisplatin followed by esophagectomy in squamous cell carcinoma of the esophagus: pathologic complete response induced by chemotherapy leads to long-term survival. J Clin Oncol 2003, 21(21):4009-4015.
141. Das A., Singh V., Fleischer D.E., Sharma V.K. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. Am J Gastroenterol 2008, 103(6):1340-1345.
142. de Boer A.G., van Lanschot J.J., van Sandick J.W., Hulscher J.B., Stalmeier P.F., de Haes J.C., et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus. J Clin Oncol 2004, 22(20):4202-4208.
143. Di Fiore F., Lecleire S., Galais M.P., Rigal O., Vie B., David I., et al. Impact of radiation schedule and chemotherapy duration in definitive chemoradiotherapy regimen for esophageal cancer. Gastroenterol Clin Biol 2006, 30(6-7):845-851.
144. Di Franco F. Iatrogenic perforation of localized oesophageal cancer. Brit J Surg 2008, 95(7):837-839.
145. Doki Y., Okada K., Miyata H., Yamasaki M., Fujiwara Y., Takiguchi S., et al. Long-term and short-term evaluation of esophageal reconstruction using the colon or the jejunum in esophageal cancer patients after gastrectomy. Dis Esophagus 2008, 21(2):132-138.
146. Donington J.S. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardio-Thorac Surg 2003, 24(4):631-637.
147. Dunkin B.J., Martinez J., Bejarano P.A., Smith C.D., Chang K., Livingstone A.S., et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc 2006, 20(1):125-130.
148. Ell C., May A., Gossner L., Pech O., Gunter E., Mayer G., et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000, 118(4):670-677.
149. El-Rayes B.F., Shields A., Zalupski M., Heilbrun L.K., Jain V., Terry D., et al. A phase II study of carboplatin and paclitaxel in esophageal cancer. Ann Oncol 2004, 15(6):960-965.
150. Ertan A., Zimmerman M., Younes M. Esophageal adenocarcinoma associated with Barretts-esophagus - long-term management with laser-ablation. Am J Gastroenterol 1995, 90(12):2201-2203.
151. Farran L., Llop J., Sans M., Kreisler E., Miro M., Galan M., et al. Efficacy of enteral decontamination in the prevention of anastomotic dehiscence and pulmonary infection in esophagogastric surgery. Dis Esophagus 2008, 21(2):159-164.
152. Ferahkose Z., Bedirli A., Kerem M., Azili C., Sozuer E.M., Akin M. Comparison of free jejunal graft with gastric pull-up reconstruction after resection of hypopharyngeal and cervical esophageal carcinoma. Dis Esophagus 2008, 21(4):340-345.
153. Frechette E.B. Esophageal cancer: outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy. J Surg Oncol 2004, 87(2):68-74.
154. Go J.T., Dumot J.A., Lopez R., Vargo J., Zuccaro G., Falk G., et al. Photodynamic therapy in Barrett's esophagus with high grade dysplasia and intra-mucosal carcinoma. Am J Gastroenterol 2006, 101(9 (Suppl)):S64. [abstract].
155. Gockel I., Sultanov F.S., Domeyer M., Goenner U., Junginger T. Developments in esophageal surgery for adenocarcinoma: a comparison of two decades. BMC Cancer 2007, 7:114. .
156. Goldberg M., Farma J., Lampert C., Colarusso P., Coia L., Frucht H., et al. Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: a phase I report. J Thorac Cardiovasc Surg 2003, 126(4):1168-1173.
157. Gossner L., May A., Sroka R., Rabenstein T., Schneider T.H., Hahn E.G., et al. Photodynamic therapy of Barrett's esophagus with high-grade dysplasia and early cancer. Gastroenterology 1998, 114(Suppl 1):A137. [abstract].
158. Gossner L., Stolte M., Sroka R., Rick K., May A., Hahn E.G., et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 1998, 114(3):448-455.
159. Govindan R., McLeod H., Mantravadi P., Fineberg N., Helft P., Kesler K., et al. Cisplatin, fluorouracil, celecoxib, and RT in resectable esophageal cancer: preliminary results. Oncology (Williston Park) 2004, 18(14 (Suppl 14)):18-21.
160. Gradauskas P., Rubikas R., Saferis V. Changes in quality of life after esophageal resections for carcinoma. Medicina (Kaunas ) 2006, 42(3):187-194. .
161. Greenwald BD, Horwhat JD, Abrams JA, Lightdale CJ, Dumot JA. Endoscopic cryotherapy ablation is safe and well-tolerated in Barrett's esophagus, esophageal dysplasia, and esophageal cancer. Digestive Disease Week 2008, May 17-22, 2008, San Diego, CA. p. 235 [abstract]. http://www.ddw.org.
162. Grosjean P., Savary J.F., Mizeret J., Wagnieres G., Woodtli A., Theumann J.F., et al. Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin. J Clin Laser Med Surg 1996, 14(5):281-287.
163. Radu A., Grosjean P., Fontolliet C., Wagnieres G., Woodtli A., Bergh H.V., et al. Photodynamic therapy for 101 early cancers of the upper aerodigestive tract, the esophagus, and the bronchi: a single-institution experience. Diagn Ther Endosc 1999, 5(3):145-154.
164. Hainsworth J.D. Concurrent chemoradiation followed by esophageal resection vs. chemoradiation alone for localized esophageal cancer. Community Oncol 2007, 4(7):431-439. .
165. Halliday B.P., Skipworth R.J., Wall L., Phillips H.A., Couper G.W., de Beaux A.C., et al. Neoadjuvant chemotherapy for carcinoma of the oesophagus and oesophago-gastric junction: a six-year experience. Int Semin Surg Oncol 2007, 4:24.
166. Heath E.I., Burtness B.A., Kleinberg L., Salem R.R., Yang S.C., Heitmiller R.F., et al. Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma. Invest New Drugs 2006, 24(2):135-140.
167. Herman L.L., Gerdes H., Mendis R., Likier H., Lightdale C.J. Photodynamic therapy for completely obstructing esophageal cancer. Gastrointest Endosc 1993, 39(2):278. [abstract].
168. Higuchi A. Evaluation of the quality of life after surgical treatment for thoracic esophageal cancer. Esophagus 2006, 3(2):53-59.
169. Higuchi K., Tanabe S., Koizumi W., Sasaki T., Nakatani K., Saigenji K., et al. Expansion of the indications for endoscopic mucosal resection in patients with superficial esophageal carcinoma. Endoscopy 2007, 39(1):36-40.
170. Imdahl A. Impact of neoadjuvant therapy of perioperative morbidity in patients with esophageal cancer. Am J Surg 2004, 187(1):64-68.
171. Ishikawa H. Clinical outcomes and prognostic factors for patients with early esophageal squamous cell carcinoma treated with definitive radiation therapy alone. J Clin Gastroenterol 2005, 39(6):495-500.
172. Jamieson N.F., Thorpe S., Mosse A., Bown S.G., Lovat L.B. Photodynamic therapy using MTHPC for early Barrett's-associated oesophageal cancers. Gut 2003, 52(Suppl 1):A46-A47. [abstract].
173. Jamieson N., Thorpe S., Mosse A., Novelli M., Lovat L., Bown S. Photodynamic therapy using mTHPC for early Barretts-associated esophageal cancer. Gastroenterology 2003, 124(4 Suppl):A298. [abstract].
174. Jin J., Liao Z., Zhang Z., Ajani J., Swisher S., Chang J.Y., et al. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2004, 60:427-436.
175. Jo W.M., Shin J.S., Lee I.S. Mid-term outcomes of side-to-side stapled anastomosis in cervical esophagogastrostomy. J Korean Med Sci 2006, 21(6):1033-1036.
176. Junginger T., Gockel I., Heckhoff S. A comparison of transhiatal and transthoracic resections on the prognosis in patients with squamous cell carcinoma of the esophagus. Eur J Surg Oncol 2006, 32(7):749-755.
177. Kashtan H., Konikoff F., Haddad R., Skornick Y. Photodynamic therapy of cancer of the esophagus using systemic aminolevulinic acid and a non laser light source: a phase I/II study. Gastrointest Endosc 1999, 49(6):760-764.
178. Kashtan H., Umansky M., Birkenfeld S., Scherubl H., Haddad R., Greenberg R., et al. Photodynamic therapy of Barrett's esophagus with dysplasia using systemic aminolevulinic acid and a non-laser light source. A phase I/II study. Gastrointest Oncol 2002, 4(2-3):153-157.
179. Katada C., Muto M., Manabe T., Boku N., Ohtsu A., Yoshida S. Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest Endosc 2003, 57(2):165-169.
180. Kelsen D.P., Winter K.A., Gunderson L.L., Mortimer J., Estes N.C., Haller D.G., et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol 2007, 25(24):3719-3725.
181. Kelsey C.R., Chino J.P., Willett C.G., Clough R.W., Hurwitz H.I., Morse M.A., et al. Paclitaxel-based chemoradiotherapy in the treatment of patients with operable esophageal cancer. Int J Radiat Oncol Biol Phys 2007, 69(3):770-776.
182. Keresztes R.S., Port J.L., Pasmantier M.W., Korst R.J., Altorki N.K. Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trial. J Thorac Cardiovasc Surg 2003, 126(5):1603-1608.
183. Kim J.-H. Treatment outcomes of 70 cases of early esophageal carcinoma: 12 years of experience. Dis Esophagus 2007, 20(4):297-300.
184. Kleinberg L., Knisely J.P., Heitmiller R., Zahurak M., Salem R., Burtness B., et al. Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2003, 56(2):328-334.
185. Kodaira T., Fuwa N., Kamata M., Furutani K., Tachibana H., Yamazaki T. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma. Anticancer Res 2006, 26(1B):471-478.
186. Kunisaki C., Makino H., Otsuka Y., Kojima Y., Takagawa R., Kosaka T., et al. Appropriate routes of reconstruction following transthoracic esophagectomy. Hepatogastroenterology 2007, 54(79):1997-2002.
187. Lee J.L., Park S.I., Kim S.B., Jung H.Y., Lee G.H., Kim J.H., et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004, 15(6):947-954.
188. Lew R.J., Scotiniotis I.A., Kochman M.L., Sanfilipo N.J., Hahn S.M., Rosato E.F., et al. Long-term outcomes of esophagectomy, endoscopic mucosal resection, or photodynamic therapy for superficial esophageal cancer. Gastrointest Endosc 2002, 55(5 Suppl):AB219. [abstract].
189. Li J.H., Guo Z.H., Jin M.L., Zhao F.Y., Cai W.M., Gao M.L., et al. Photodynamic therapy in the treatment of malignant tumours: an analysis of 540 cases. J Photochem Photobiol B 1990, 6(1-2):149-155.
190. Lovat L.B., Thorpe S.M., Francis H., Buonoacorssi G., Moss S., Bown S.G. Photodynamic therapy using 5 amino laevulinic acid for high grade dysplasia in Barrett's oesophagus. Gut 2000, 46(Suppl 2):A93. [abstract].
191. Kelty C.J., Ackroyd R., Brown N.J., Brown S.B., Stephenson T.J., Reed M.W.R. Photodynamic therapy (PDT) for Barrett's oesophagus: establishing the optimum dose of 5-aminolaevulinic acid (ALA). Gut 2002, 50(Suppl 2):A123. [abstract].
192. Luechakiettisak P., Kasetsunthorn S. Comparison of hand-sewn and stapled in esophagogastric anastomosis after esophageal cancer resection: a prospective randomized study. J Med Assoc Thai 2008, 91(5):681-685.
193. Luu T.D., Gaur P., Force S.D., Staley C.A., Mansour K.A., Miller J.I., et al. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer. Ann Thorac Surg 2008, 85(4):1217-1223.
194. Ma J.Y., Wu Z., Wang Y., Zhao Y.F., Liu L.X., Kou Y.L., et al. Clinicopathologic characteristics of esophagectomy for esophageal carcinoma in elderly patients. World J Gastroenterol 2006, 12(8):1296-1299.
195. Maish M.S., DeMeester S.R. Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma. Ann Thorac Surg 2004, 78(5):1777-1782.
196. Malhi-Chowla N., Wolfsen H.C., DeVault K.R. Esophageal dysmotility in patients undergoing photodynamic therapy. Mayo Clin Proc 2001, 76(10):987-989.
197. May A., Gossner L., Behrens A., Kohnen R., Vieth M., Stolte M., et al. A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 2003, 58(2):167-175.
198. Pech O. Endoscopic resection of superficial esophageal squamous-cell carcinomas: Western experience. Am J Gastroenterol 2004, 99(7):1226-1232.
199. van Meerten E., Muller K., Tilanus H.W., Siersema P.D., Eijkenboom W.M., van D.H., et al. Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study. Brit J Cancer 2006, 94(10):1389-1394.
200. Michel P., Adenis A., Di F.F., Boucher E., Galais M.P., Dahan L., et al. Induction cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial. Brit J Cancer 2006, 95(6):705-709.
201. Miyashita M. Response to preoperative chemotherapy affects prognosis in esophageal cancer. Dis Esophagus 2003, 16(2):99-101.
202. Monnier P., Savary M., Fontolliet C., Wagnieres Chatelain G.A., Cornaz P., Depeursinge C., et al. Photodetection and photodynamic therapy of 'early' squamous cell carcinomas of the pharynx, oesophagus and tracheo-bronchial tree. Lasers Med Sci 1990, 5(2):149-168.
203. Monnier P., Fontolliet C., Ollyo J.B. Endoscopic findings of 100 early-stage esophageal cancers. Diagn Ther Endosc 1994, 1(2):83-92.
204. Moorjani N., Junemann-Ramirez M., Judd O., Fox B., Rahamim J.S. Endoscopic ultrasound in esophageal carcinoma: comparison with multislice computed tomography and importance in the clinical decision making process. Minerva Chir 2007, 62(4):217-223.
205. Morgan M.A., Lewis W.G., Hopper A.N., Escofet X., Havard T.J., Brewster A.E., et al. Prospective comparison of transthoracic versus transhiatal esophagectomy following neoadjuvant therapy for esophageal cancer. Dis Esophagus 2007, 20(3):225-231.
206. Morita M., Egashira A., Yoshida R., Ikeda K., Ohgaki K., Shibahara K., et al. Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus. J Gastroenterol 2008, 43(5):345-351.
207. Murakami Y. Results of the 1999-2001 Japanese patterns of care study for patients receiving definitive radiation therapy without surgery for esophageal cancer. Jpn J Clin Oncol 2007, 37(7):493-500.
208. Natsugoe S., Okumura H., Matsumoto M., Uchikado Y., Setoyama T., Yokomakura N., et al. Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esophagus 2006, 19(6):468-472.
209. Nemoto K., Takai K., Ogawa Y., Sakayauchi T., Sugawara T., Jingu K., et al. Salvage radiation therapy for residual superficial esophageal cancer after endoscopic mucosal resection. Int J Radiat Oncol Biol Phys 2005, 63(5):1290-1294.
210. Oh D.S., Hagen J.A., Chandrasoma T., Dunst C.M., DeMeester S.R., Alavi M., et al. Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus. J Am Coll Surg 2006, 203(2):152-161.
211. Ohana M., Mino-Kenudson M., Ban S., Puricelli W., Nishioka N. Frequent persistence of dysplasia by systematic pathological evaluation after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or early adenocarcinoma. Gastroenterology 2005, 129(3):1109. [abstract].
212. Ohana M., Mino-Kenudson M., Ban S., Puricelli W., Nishoka N. Frequent persistence of dysplasia by systematic pathological evaluation after photodynamic therapy for Barrett's Esophagus with high-grade dysplasia or early adenocarcinoma. Gastrointest Endosc 2005, 61(5):AB94. [abstract].
213. Ohana M., Mino-Kenudson M., Ban S.C., Puricelli W., Nishioka N., Lauwers G. Frequent persistence of dysplasia by systematic pathological evaluation after photodynamic therapy for Barrett's Esophagus with high-grade dysplasia or early adenocarcinoma. Gastroenterology 2005, 128(4 (Suppl 2)):A72. [abstract].
214. Okuyama M., Motoyama S., Suzuki H., Saito R., Maruyama K., Ogawa J. Hand-sewn cervical anastomosis versus stapled intrathoracic anastomosis after esophagectomy for middle or lower thoracic esophageal cancer: a prospective randomized controlled study. Surg Today 2007, 37(11):947-952.
215. Omloo J.M., Lagarde S.M., Hulscher J.B., Reitsma J.B., Fockens P., van D.H., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 2007, 246(6):992-1000.
216. Overholt B., Panjehpour M., Tefftellar E., Rose M. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. Gastrointest Endosc 1993, 39(1):73-76.
217. Overholt B.F., Panjehpour M. Photodynamic therapy for Barrett's esophagus: cardiac and pulmonary effects. Gastroenterology 1996, 110(4 Suppl):A220. [abstract].
218. Oyama T., Tomori A., Hotta K., Morita S., Kominato K., Tanaka M., et al. Endoscopic submucosal dissection of early esophageal cancer. Clin Gastroenterol Hepatol 2005, 3(7 (Suppl 1)):S67-S70.
219. Patrice T., Foultier M.T., Yactayo S., Douet M.C., Maloisel F., Le B.L. Endoscopic photodynamic therapy with haematoporphyrin derivative in gastroenterology. J Photochem Photobiol B 1990, 6(1-2):157-165.
220. Peters F., Kara M., Rosmolen W., Ten Kate F., Bultje B., Krishnadath S., et al. Endoscopic resection combined with photodynamic therapy for high grade dysplasia and early cancer in Barrett's esophagus. Gastrointest Endosc 2004, 59(5 Suppl):AB251. [abstract].
221. Peters F.R., Kara M.A., Rosmolen W.D., Aalders M.C.G., Ten Kate F.J.W., Bultje B.C., et al. Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus. Gastrointest Endosc 2005, 61(4):506-514.
222. Peters F.P., Kara M.A., Rosmolen W.D., Ten Kate F.J.W., Bultje A.C., Krishnadath K.K., et al. Endoscopic resection combined with photodynamic therapy for high grade dysplasia and early cancer in Barrett's esophagus. Eur J Gastroenterol Hepatol 2005, 17(1):A29-A30. [abstract].
223. Polee M.B., Tilanus H.W., Eskens F.A., Hoekstra R., van der Burg M.E., Siersema P.D., et al. Phase II study of neo-adjuvant chemotherapy with paclitaxel and cisplatin given every 2 weeks for patients with a resectable squamous cell carcinoma of the esophagus. Ann Oncol 2003, 14(8):1253-1257.
224. Portale G., Peters J.H., Hsieh C.C., Hagen J.A., DeMeester S.R., DeMeester T.R. Can clinical and endoscopic findings accurately predict early-stage adenocarcinoma?. Surg Endosc 2006, 20(2):294-297.
225. Pouw R.E., Gondrie J.J., Curvers W.L., Sondermeijer C.M., Ten Kate F.J., Bergman J.J. Successful balloon-based radiofrequency ablation of a widespread early squamous cell carcinoma and high-grade dysplasia of the esophagus: a case report. Gastrointest Endosc 2008, 68(3):537-541.
226. Pouw RE, Gondrie JJ, Van Vilsteren FG, Sondermeijer C, Rosmolen W, Curvers WL, et al. A promising new combined treatment modality for Barrett's esophagus containing early neoplasia: endoscopic resection followed by step-wise circumferential and focal radiofrequency energy ablation. Digestive Disease Week 2008, May 17-22, 2008, San Diego, CA, Bethesda, MD. p. M1323 [abstract]. http://www.ddw.org.
227. Pouw RE, Gondrie JJ, Van Vilsteren FG, Sondermeijer C, Rosmolen W, Curvers WL, et al. Complications following circumferential radiofrequency energy ablation of Barrett's esophagus containing early neoplasia. Digestive Disease Week 2008, May 17-22, 2008, San Diego, CA, Bethesda, MD. p. S1475 [abstract]. http://www.ddw.org.
228. Pouw RE, Gondrie JJ, Van Vilsteren FG, Sondermeijer C, Rosmolen W, Curvers WL, et al. Stepwise circumferential and focal radiofrequency ablation of Barrett's esophagus with high-grade dysplasia or intramucosal cancer. Digestive Disease Week 2008, May 17-22, 2008, San Diego, CA, Bethesda, MD. p. 215 [abstract]. http://www.ddw.org.
229. Pouw RE, Sondermeijer C, Ten Kate FJ, Fockens P, Eisendrath P, Deviere JM, et al. Stepwise circumferential and focal radiofrequency energy ablation of Barrett's esophagus with early ablation of Barrett's esophagus with early neoplasia: first European multi-centre trial. Digestive Disease Week 2008, May 17-22, 2008, San Diego, CA, Bethesda, MD. p. S1441 [abstract]. http://www.ddw.org.
230. Rahmani E.Y., Turpin C., Arney K. Photodynamic therapy for dysplastic Barrett's esophagus and early esophageal adenocarcinoma should be first line therapy!. Gastrointest Endosc 2004, 59(5 (Suppl)):AB250. [abstract].
231. Rentz J., Bull D., Harpole D., Bailey S., Neumayer L., Pappas T., et al. Transthoracic versus transhiatal esophagectomy: a prospective study of 945 patients. J Thorac Cardiovasc Surg 2003, 125(5):1114-1120.
232. Reynolds J.V. Neoadjuvant chemoradiation may increase the risk of respiratory complications and sepsis after transthoracic esophagectomy. J Thorac Cardiovasc Surg 2006, 132(3):549-555.
233. Rizzetto C., DeMeester S.R., Hagen J.A., Peyre C.G., Lipham J.C., DeMeester T.R. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma. J Thorac Cardiovasc Surg 2008, 135(6):1228-1236.
234. Rohatgi P.R., Swisher S.G., Correa A.M., Wu T.T., Liao Z., Komaki R., et al. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 2005, 104(7):1349-1355.
235. Rutegard M., Lagergren P. No influence of surgical volume on patients' health-related quality of life after esophageal cancer resection. Ann Surg Oncol 2008, 15(9):2380-2387.
236. Sanfilippo N.J., Hsi A., DeNittis A.S., Ginsberg G.G., Kochman M.L., Friedberg J.S., et al. Toxicity of photodynamic therapy after combined external beam radiotherapy and intraluminal brachytherapy for carcinoma of the upper aerodigestive tract. Lasers Surg Med 2001, 28(3):278-281.
237. Schaffer M., Corti L., Hollenhorst H., Boso C., Schaffer P.M., Busch M., et al. Combined treatment modality of esophageal cancer: Radiation therapy (RT) with photodynamic therapy (PDT). Eur J Cancer 1997, 33(Suppl 5):S29. [abstract].
238. Schembre D.B., Huang J.L., Lin O.S., Cantone N., Low D.E. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy. Gastrointest Endosc 2008, 67(4):595-601.
239. Seruga B. Preoperative concomitant chemoradiotherapy in esophageal cancer. Radiol Oncol 2006, 40(4):231-237.
240. Seung S.K., Smith J.W., Molendyk J., Bader S.B., Phillips M., Regan J., et al. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification. Semin Oncol 2004, 31(6 (Suppl 18)):13-19.
241. Shimoyama S.I. The useful combination of a higher frequency miniprobe and endoscopic submucosal dissection for the treatment of T1 esophageal cancer. Surg Endosc 2006, 20(3):434-438.
242. Smith B.R., Hinojosa M.W., Reavis K.M., Nguyen N.T. Outcomes of esophagectomy according to surgeon's training: general vs. thoracic. J Gastrointest Surg 2008, 12(11):1907-1911.
243. Sonnenberg A., Fennerty M.B. Medical decision analysis of chemoprevention against esophageal adenocarcinoma. Gastroenterology 2003, 124(7):1758-1766.
244. Stahl M., Oliveira J. Esophageal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008, 19(Suppl 2):ii21-ii22.
245. Stein H.J., Feith M., Bruecher B.L., Naehrig J., Sarbia M., Siewert J.R. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg 2005, 242(4):566-573.
246. Sun S.P., Liu Y.Z., Ye T., Zhang W., Shen W.B., Shi J.L., et al. Randomized clinical trial on seven-day-per-week continuous accelerated irradiation for patients with esophageal carcinoma: preliminary report on tumor response and acute toxicity. World J Gastroenterol 2006, 12(43):7047-7050.
247. Tachibana M., Yoshimura H., Kinugasa S., Shibakita M., Dhar D.K., Ueda S., et al. Postoperative chemotherapy vs. chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial. Eur J Surg Oncol 2003, 29(7):580-587.
248. Tachibana M. Clinicopathologic features of superficial esophageal cancer: Results of consecutive 100 patients. Ann Surg Oncol 2008, 15(1):104-116.
249. Tajiri H., Daikuzono N., Joffe S.N., Oguro Y. Photoradiation therapy in early gastrointestinal cancer. Gastrointest Endosc 1987, 33(2):88-90.
250. Terrosu G., Cedolini C., Bresadola V., Baccarani U., Uzzau A., Signor M., et al. Preoperative chemoradiotherapy in cancer of the thoracic esophagus. Dis Esophagus 2003, 16(1):9-16.
251. Tetzlaff E.D. Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction. Dis Esophagus 2008, 21(7):575-581.
252. Urba S.G., Orringer M.B., Ianettonni M., Hayman J.A., Satoru H. Concurrent cisplatin, paclitaxel, and radiotherapy as preoperative treatment for patients with locoregional esophageal carcinoma. Cancer 2003, 98(10):2177-2183.
253. van Heijl M., Omloo J.M., van Berge Henegouwen M.I., Busch O.R., Tilanus H.W., Bossuyt P.M., et al. Neoadjuvant therapy monitoring with PET and CT in esophageal cancer (NEOPEC-trial). BMC Med Phys 2008, 8:3.
254. van Meerten E., van der G.A., Looman C.W., Tilanus H.W., Muller K., Essink-Bot M.L. Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma. Int J Radiat Oncol Biol Phys 2008, 71(1):160-166.
255. Vuong T. The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy. Int J Radiat Oncol Biol Phys 2005, 63(3):758-764.
256. Walther B., Johansson J., Johnsson F., Von Holstein C.S., Zilling T. Cervical or thoracic anastomosis after esophageal resection and gastric tube reconstruction: a prospective randomized trial comparing sutured neck anastomosis with stapled intrathoracic anastomosis. Ann Surg 2003, 238(6):803-812.
257. Wang K.K. Multimodality therapy for gastroesophageal cancers. J Gastrointest Surg 2002, 6(4):527-531.
258. Wang H., Ryu J., Gandara D., Bold R.J., Urayama S., Tanaka M., et al. A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer. J Thorac Oncol 2007, 2(2):153-157.
259. Wang S., Liao Z., Wei X., Liu H.H., Tucker S.L., Hu C., et al. Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. J Thorac Oncol 2008, 3(3):277-282.
260. Wang S.J., Wu M.L., Zhang L.W., Guo X.Q., Xu Z.B., Er L.M., et al. The value of endoscopic mucosal resection for dysplasia and early-stage cancer of the esophagus and gastric cardia. Zhonghua Zhong Liu Za Zhi 2008, 30(11):853-857.
261. Wolfsen H.C., Woodward T.A. Photodynamic therapy for dysplastic Barrett's esophagus and mucosal, esophageal adenocarcinoma: the value of endoscopic ultrasound and results using the bare fiber technique. Gastrointest Endosc 2000, 51(Part 2(4)):AB116. [abstract].
262. Wolfsen H.C., Woodward T.A., Raimondo M. Photodynamic therapy for dysplastic Barrett esophagus and early esophageal adenocarcinoma. Mayo Clin Proc 2002, 77(11):1176-1181.
263. Wolfsen H.C., Hemminger L.L., Wallace M.B., DeVault K.R. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther 2004, 20(10):1125-1131.
264. Wolfsen H.C., Hemminger L.L., Raimondo M., Woodward T.A. Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma. South Med J 2004, 97(9):827-830.
265. Wolfsen H.C., Hemminger L.L. Salvage photodynamic therapy for persistent esophageal cancer after chemoradiation therapy. Photodiagn Photodyn Ther 2006, 3(1):11-14.
266. Wood D., Block K. Photodynamic therapy (PDT) may not reliably ablate T-2 esophageal cancer (ACA) but does not complicate subsequent esophago-gastrectomy. Gastrointest Endosc 1999, 49(4 (Part 2)):AB107. [abstract].
267. Yano T., Muto M., Minashi K., Ohtsu A., Yoshida S. Photodynamic therapy as salvage treatment for local failures after definitive chemoradiotherapy for esophageal cancer. Gastrointest Endosc 2005, 62(1):31-36.
268. Yoshinaga S., Gotoda T., Kusano C., Oda I., Nakamura K., Takayanagi R. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc 2008, 67(2):202-209.
269. Zingg U. High dose N-acetylcysteine to prevent pulmonary complications in partial or total transthoracic esophagectomy: results of a prospective observational study. Dis Esophagus 2007, 20(5):399-405.